Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division
March 29, 2023
Göttingen -- At today’s meeting, the Supervisory Board of Sartorius AG appointed Alexandra Gatzemeyer, Ph.D., as Member of the Executive Board, effective May 1, 2023. From June 16, 2023, Alexandra Gatzemeyer will succeed Gerry Mackay, Board Member and Head of the Lab Products & Services division, who will hand over duties in the course of [...]
March 29, 2023
Olympus Corporation ("Olympus") hereby announces that the closing date of the transfer of all shares of Evident Corporation, a specified subsidiary of Olympus, to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”) (the "Transfer") has been scheduled for April 3, [...]
Admera Health Announces its Acquisition of a NovaSeq X Plus
March 29, 2023
SOUTH PLAINFIELD, NEW JERSEY, USA -- Admera Health, a leading provider of Next-Generation Sequencing services for researchers worldwide, has announced the acquisition of an Illumina NovaSeq X Plus sequencer to bolster its offering. The NovaSeq X Plus is a cutting-edge technology that enables high-throughput sequencing and supports a wide range of applications, including whole genome sequencing, transcriptome sequencing, targeted sequencing, [...]
Swedish Olink technology enables further development of South African research and innovation
March 29, 2023
UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) today announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink technology and has become the first service provider using the Olink® Target and Olink® Flex platforms for targeted protein biomarker discovery on the African continent. D-CYPHR is a new facility co-founded by [...]
Notice Concerning Postponement of Closing of Transfer of Shares of Evident Corporation
March 29, 2023
Tokyo — Evident Corporation ("Evident") announces that the closing date of the transfer of all shares of Evident, a specified subsidiary of Olympus, to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”) has been scheduled for April 3, 2023. Reasons for [...]
Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
March 29, 2023
Through AI/ML-enabled platform with a biology-first approach, Genialis looks to propel drug development, diagnostics and treatment planning Boston & Ljubljana, Slovenia – Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the way diseases are [...]
AmbioPharm To Utilize YMC Twin-Column Chromatography in Large Scale Peptide Production
March 28, 2023
NORTH AUGUSTA, S.C. and DEVENS, Mass. -- AmbioPharm, a worldwide leader in peptide API CDMO services, announces the acquisition of new, disruptive, peptide purification technology developed by YMC which leverages several of YMC’s patented1 twin-column purification processes. Twin-column chromatography or Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) is a continuous chromatographic process which collects a high purity center cut fraction and internally recycles mixed [...]
March 28, 2023
SINGAPORE -- Becton Dickinson Holdings Pte Ltd (BD), a global leader in life science technologies, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have announced an extended research partnership that will focus on deep immunophenotyping of human tissues using spectral flow cytometry panels to bring forth discoveries that can be translated [...]
MIMETAS and Astellas Enter into Strategic Partnership on Immuno-oncology
March 28, 2023
Leiden – MIMETAS, a global leader in human disease modeling announces that it has entered into a strategic partnership with Astellas Pharma Inc., a global pharmaceutical company. The partnership comprises utilizing MIMETAS’ comprehensive tumor models to support the next generation of immuno-oncological therapies. “We are excited to make this next step in our longstanding collaboration with [...]
March 28, 2023
The New Assay Will Screen Patients for Clinical Trials and Help Increase Data Analysis for Clinical Researchers BOSTON & LAUSANNE, Switzerland -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Acutis Diagnostics, a specialized medical laboratory, will use SOPHiA DDM™ to develop [...]

